Literature DB >> 1758523

Evaluation of renal handling of uric acid in essential hypertension: hyperuricemia related to decreased urate secretion.

A Tykarski1.   

Abstract

The tubular transport of urate was studied in 40 hypertensive patients and in 20 normal subjects by means of pyrazinamide and benzbromarone tests. There was a marked decrease in urate excretion per nephron in hyperuricemic patients with essential hypertension. Serum uric acid correlated inversely with fractional excretion of urate (r = -0.7450, p less than 0.001). Presecretory and postsecretory reabsorption of urate did not significantly differ between hypertensive patients with high uric acid levels and control subjects. Urate secretion was significantly reduced in hypertensive patients and in those with hyperuricemia showed a twofold decrease. Serum uric acid correlated inversely with tubular secretion of urate (r = -0.7091, p less than 0.001) in hypertensive patients. These findings indicate that impaired tubular secretion of urate is a potential mechanism of hyperuricemia in essential hypertension.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1758523     DOI: 10.1159/000186593

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  10 in total

Review 1.  Hyperuricemia and renal function.

Authors:  L M Ruilope; J Garcia-Puig
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

2.  Fenofibrate and losartan.

Authors:  T Bardin
Journal:  Ann Rheum Dis       Date:  2003-06       Impact factor: 19.103

Review 3.  Recent advances in the epidemiology of gout.

Authors:  Kenneth G Saag; Ted R Mikuls
Journal:  Curr Rheumatol Rep       Date:  2005-06       Impact factor: 4.592

4.  Gout, diuretics and the kidney.

Authors:  E Pascual; M Perdiguero
Journal:  Ann Rheum Dis       Date:  2006-08       Impact factor: 19.103

5.  Hyperuricaemia, chronic kidney disease, and outcomes in heart failure: potential mechanistic insights from epidemiological data.

Authors:  Gerasimos S Filippatos; Mustafa I Ahmed; James D Gladden; Marjan Mujib; Inmaculada B Aban; Thomas E Love; Paul W Sanders; Bertram Pitt; Stefan D Anker; Ali Ahmed
Journal:  Eur Heart J       Date:  2011-01-03       Impact factor: 29.983

6.  Serum uric Acid in smokers.

Authors:  Bassam E Hanna; Jamal M Hamed; Luma M Touhala
Journal:  Oman Med J       Date:  2008-10

Review 7.  Uric acid and the vasculature.

Authors:  Dalila B Corry; Michael L Tuck
Journal:  Curr Hypertens Rep       Date:  2006-05       Impact factor: 5.369

Review 8.  Epidemiology, risk factors, and lifestyle modifications for gout.

Authors:  Kenneth G Saag; Hyon Choi
Journal:  Arthritis Res Ther       Date:  2006-04-12       Impact factor: 5.156

9.  Functional and Structural Characterization of Purine Nucleoside Phosphorylase from Kluyveromyces lactis and Its Potential Applications in Reducing Purine Content in Food.

Authors:  Durga Mahor; Anu Priyanka; Gandham S Prasad; Krishan Gopal Thakur
Journal:  PLoS One       Date:  2016-10-21       Impact factor: 3.240

10.  Uric acid as a marker for renal dysfunction in hypertensive women on diuretic and nondiuretic therapy.

Authors:  Rodolfo L Borges; Andrea H Hirota; Beata M Quinto; Artur B Ribeiro; Maria T Zanella; Marcelo C Batista
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-05       Impact factor: 3.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.